These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 20565769)

  • 1. The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Najar M; Piccart M; Ghanem G; Body JJ; Journé F
    BMC Cancer; 2010 Jun; 10():298. PubMed ID: 20565769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts.
    Lee YC; Huang CF; Murshed M; Chu K; Araujo JC; Ye X; deCrombrugghe B; Yu-Lee LY; Gallick GE; Lin SH
    Oncogene; 2010 Jun; 29(22):3196-207. PubMed ID: 20228840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
    Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
    Garcia-Gomez A; Ocio EM; Crusoe E; Santamaria C; Hernández-Campo P; Blanco JF; Sanchez-Guijo FM; Hernández-Iglesias T; Briñón JG; Fisac-Herrero RM; Lee FY; Pandiella A; San Miguel JF; Garayoa M
    PLoS One; 2012; 7(4):e34914. PubMed ID: 22539950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
    Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2.
    Mostafa NZ; Fitzsimmons R; Major PW; Adesida A; Jomha N; Jiang H; Uludağ H
    Connect Tissue Res; 2012; 53(2):117-31. PubMed ID: 21966879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
    Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
    J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
    Araujo JC; Poblenz A; Corn P; Parikh NU; Starbuck MW; Thompson JT; Lee F; Logothetis CJ; Darnay BG
    Cancer Biol Ther; 2009 Nov; 8(22):2153-9. PubMed ID: 19855158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.
    Park JB
    J Surg Res; 2012 Mar; 173(1):99-104. PubMed ID: 21035140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells.
    Borriello A; Caldarelli I; Basile MA; Bencivenga D; Tramontano A; Perrotta S; Della Ragione F; Oliva A
    PLoS One; 2011; 6(12):e28555. PubMed ID: 22164306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts.
    Igarashi M; Kamiya N; Hasegawa M; Kasuya T; Takahashi T; Takagi M
    J Mol Histol; 2004 Jan; 35(1):3-10. PubMed ID: 15323344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
    Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
    J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anagliptin stimulates osteoblastic cell differentiation and mineralization.
    Dong C; Yang H; Wang Y; Yan X; Li D; Cao Z; Ning Y; Zhang C
    Biomed Pharmacother; 2020 Sep; 129():109796. PubMed ID: 32559615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
    Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
    Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.
    Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
    Osteoporos Int; 2013 May; 24(5):1647-61. PubMed ID: 23104199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myricetin 3-
    Karadeniz F; Oh JH; Jo HJ; Seo Y; Kong CS
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.